Skip to content

Clinical trials

Phase 3 Pulmonary Embolism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Phase 3 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20062
20075
20081
20092
20101
20122
20141
20152
20161
20173
20201
20222
20231
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting5
Terminated5
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals4
Bayer3
Bristol-Myers Squibb3
Daiichi Sankyo3
Sanofi3
Academic and Community Cancer Research United2
Anthos Therapeutics, Inc.2
University of Maryland, Baltimore2
Boston Scientific Corporation1
Crux Biomedical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism33
Venous Thrombosis20
Venous Thromboembolism17
Thrombosis6
Neoplasms4
Thromboembolism3
Intracranial Thrombosis2
Neoplasm Metastasis2
Atrial Fibrillation1
Brain Neoplasms1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.